Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC)

Historical Holders from Q1 2025 to Q3 2025

Symbol
TDAC on Nasdaq
CUSIP
G9008W105
Type / Class
Equity / Class A ordinary shares, par value $0.0001 per share
Shares outstanding
17.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
15.3M
Holdings value
$156M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
41
Number of buys
9
Number of sells
-12
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WOLVERINE ASSET MANAGEMENT LLC 9.03% +14.8% $16.1M $2.09M 1.56M +14.9% WOLVERINE ASSET MANAGEMENT LLC Sep 30, 2025
AQR CAPITAL MANAGEMENT LLC 6.38% -24.8% $11.1M -$3.88M 1.1M -25.9% AQR Capital Management, LLC Mar 31, 2025
BANK OF MONTREAL /CAN/ 4.64% -19.2% $8.06M -$2.02M 800K -20% Bank of Montreal Jun 30, 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.3% -58% $4.03M -$5.04M 400K -55.6% Healthcare of Ontario Pension Plan Trust Fund Mar 31, 2025

Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15.3M $156M +$15.1M $10.35 41
2025 Q2 14M $142M +$30.1M $10.27 38
2025 Q1 11.2M $112M +$112M $10.08 30